Cancer Causing Asbestos Threat: Sri Lanka halts imports of Johnson & Johnson Baby Powder Medical Dialogues Bureau1 Feb 2019 12:51 PM ISTCOLOMBO (Reuters) - Sri Lanka has halted imports of Johnson & Johnson Baby Powder until the company proves its product is free from cancer-causing...
Pfizer quarterly profit in line, touts pipeline of future products Medical Dialogues Bureau31 Jan 2019 9:05 AM ISTOn a call with analysts, new Chief Executive Albert Bourla said Pfizer had "the best pipeline in our history," and predicted that the company would...
Novartis Aimovig not cost effective: UK price watchdog Medical Dialogues Bureau11 Jan 2019 9:00 AM ISTNovartis, whose U.K. price for Aimovig is about 5,000 pounds ($6,374) annually but which was offering discounts, is counting on the medicine to be a...
New York City launches $100 million universal health insurance program Medical Dialogues Bureau9 Jan 2019 9:00 AM ISTNEW YORK: New York City recently launched a $100 million health insurance program to cover 600,000 uninsured city residents, including those unable to...
Novartis to launch epinephrine-rival to EpiPens Farhat Nasim7 Dec 2018 9:30 AM ISTNew Delhi: Novartis AG said its U.S. unit Sandoz Inc will launch Adamis Pharmaceuticals Corp's emergency allergy shots next year in the United States,...
FDA approves new blood cancer treatment from Pfizer Medical Dialogues Bureau22 Nov 2018 9:15 AM ISTThe U.S. Food and Drug Administration on Wednesday approved Pfizer Inc's drug to treat a form of blood cancer in newly diagnosed patients as a...
